MSTM, LLC

Medtech

Advanced mass spectrometry ion source and sampling device for direct detection of pathogens, biomarkers, and hazardous materials from surfaces and biological samples

mstmsolutions.com →
Grants
$1.7M
5 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
2
0 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase II · STTR Phase II: Novel Ionization Process for Materials Characterization using Mass Spectrometry$884,191
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Robust High-Throughput Mass Spectrometry Through Vacuum Matrix Assisted Ionization$225,000
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase I · Development of multimode vacuum ionization for use in medical diagnostics$159,060
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · Development of multimode vacuum ionization for use in medical diagnostics$159,060
Federal grantDepartment of Health and Human Services · Phase I · Developing Technology to Remotely Measure Molecular Composition$258,586
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
810Kerecis hf—$3.5M
811Unify Medical Inc.—$2.8M
812Fresenius Medical Care South Grove City, LLC—$2.3M
813MSTM, LLC——
814Siesta Medical, Inc.—$1.9M
815NeuMoDx Molecular, Inc.—$55M
816Soliton, Inc.—$15M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 2
  • Multi-mode Ionization Apparatus And Uses Thereofapplication
  • Vacuum Chamber Assembly with Multiple Functions to Maximize Universality and Performanceapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.